ANAPLASTIC THYROID CANCERS HARBOR NOVEL ONCOGENIC MUTATIONS OF THE ALK GENE

• 1. 一种基于高通量测序检测非小细胞肺癌致癌基因突变的多重PCR引物、试剂盒和方法 [P] . 中国专利： CN107723354B . 2021.09.07
• 2. 编码活化致癌基因突变肽的免疫调节治疗性MRNA组合物 [P] . 中国专利： CN110430894A . 2019-11-08
• 3. Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene [P] . 美国专利： US9150929B2 . 2015-10-06

  机译： 间变性甲状腺癌具有ALK基因的新致癌突变

• 4. ANAPLASTIC THYROID CANCERS HARBOR NOVEL ONCOGENIC MUTATIONS OF THE ALK GENE [P] . 世界知识产权组织专利： WO2012158880A3 . 2013-01-24

  机译： 无性甲状腺癌癌基因的致癌突变

• 5. ANAPLASTIC THYROID CANCERS HARBOR NOVEL ONCOGENIC MUTATIONS OF THE ALK GENE [P] . 世界知识产权组织专利： WO2012158880A2 . 2012-11-22

  机译： 无性甲状腺癌癌基因的致癌突变

• 1. Relationship between molecular changes in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations in lung adenocarcinoma [J] . Rina Na, Wei Luan, Yinzai He, 中德临床肿瘤学杂志（英文版） . 2021,第004期
• 2. Relationship between molecular changes in epidermal growth factor receptor(EGFR)and anaplastic lymphoma kinase(ALK)mutations in lung adenocarcinoma [J] . Rina Na, Wei Luan, Yinzai He, 肿瘤学与转化医学（英文） . 2021,第004期
• 3. Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations [J] . Yan Zhang, Zheng Wang, Xuezhi Hao, 中国癌症研究（英文版） . 2017,第001期
• 4. Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene. [J] . Murugan AK, Xing M Cancer research: The official organ of the American Association for Cancer Research, Inc . 2011,第13期
• 5. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer [J] . Latteyer Soeren, Tiedje Vera, Koenig Katharina, Endocrine. . 2016,第3期
• 6. Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment. [J] . Camidge DR, Kono SA, Flacco A, Clinical cancer research: an official journal of the American Association for Cancer Research . 2010,第22期
• 7. Functional characterization of ubiquitination profile changes induced by oncogenic protein NPM-ALK in ALK~(+) anaplastic large cell lymphoma cells [C] . Fang Wu, Peng Wang, Raymond Lai, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010
• 8. Autophagy induced by cooperating oncogenic mutations is essential for the cancer phenotype and requires the expression of the novel cooperation response gene Plac8 [D] . Kinsey, Conan Grant 2010
• 9. Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK Gene [O] . Avaniyapuram Kannan Murugan, Mingzhao Xing -1
• 10. Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment [O] . D. Ross Camidge, Scott A. Kono, Antonella Flacco, 2010

• 1. IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors： a report of the European Organization for Research and Treat- ment of Cancer Brain Tumor Group [J] . van den Bent M J Dubbink HJ Marie Y Brandes AA Taphoorn MJ Wesseling P Frenay M Tijssen CC Lacombe D ldbaih A van Marion R Kros JM Dinjens WN Gorlia T. Sanson M. . 中国神经肿瘤杂志 . 2010,第1期
• 2. Oncogenic driver mutations in non-small cell lung cancer: Past, present and future [J] . Mathieu Chevallier ,Maxime Borgeaud ,Alfredo Addeo . 世界临床肿瘤学杂志：英文版 . 2021,第4期
• 3. 卵巢癌致癌基因和抑癌基因的研究现状 [C] . 郑敏 . 第三届中国肿瘤学术大会 . 2004
• 4. 427例甲状腺癌临床特征及侵袭性甲状腺癌基因突变情况的分析 [A] . 彭丹 . 2020